BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2007
View Archived Issues
Avocado extract shows in vitro activity against skin fungal pathogens
Read More
New therapeutic agents for glaucoma disclosed in recent Aerie patent
Read More
Novel treatment options for hematological disorders disclosed in recent AstraZeneca and IRM patents
Read More
Recent patents cover novel therapeutic agents for cardiovascular disorders
Read More
AN-2728: a novel antipsoriatic profiled at Anacor
Read More
elbion and Wyeth team up on PDE10 inhibitors for CNS disorders
Read More
Avicena completes dose-escalating portion of chronic toxicology study of PD- 02
Read More
Transtec shown to be safe and effective for treatment of cancer pain
Read More
Kuros begins phase II bone regeneration study
Read More
GSK reports on new HCV RNA polymerase inhibitor
Read More
ACT-078573 shows improvement in sleep efficiency in primary insomnia
Read More
NXY-059 safe in acute cerebral hemorrhage: CHANT study results
Read More
Benefit seen in some ischemic stroke patients given ONO-2506
Read More
WP-760 displays selectivity against melanoma cells in vitro
Read More
Clinical data on vinflunine in metastatic breast cancer presented
Read More
Favorable data on the gemcitabine/Myocet combination from a phase II trial
Read More
Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC
Read More
MitoQ begins phase II study to reduce liver damage in HCV patients
Read More
Direct thrombin inhibitor flovagatran set to enter registrational program
Read More
MultiCell makes progress toward phase IIb study of MCT-125 in MS
Read More
RX-10100 to be studied in NINDS Anticonvulsant Screening Program
Read More
Elacyt to be studied for metastatic colorectal cancer
Read More
Orion and Abbott continue discussions on phase III study of levosimendan
Read More
European orphan drug designation for Fodosine in CTCL
Read More
Genta to appeal Genasense non-approvable letter in CLL
Read More
Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma
Read More
Pfizer to acquire BioRexis Pharmaceutical
Read More
European label extension sought for Evoltra for elderly patients with AML
Read More
Pro-Pharmaceuticals commences NDA filing for Davanat
Read More
Priority review for Lovenox sNDA in acute STEMI
Read More
